M. Mazzon

A clinical stage LMW-DS drug inhibits cell infection by coronaviruses and modulates reactive cytokine release from microglia

This study evaluates the LMW-DS drug ILB(R) for inhibiting coronavirus infection and modulating cytokine release from microglia, showing it blocks ACE2:spike interaction and reduces pro-inflammatory cytokines.

A clinical stage LMW-DS drug inhibits infection of human cells by Dengue, Zika and Yellow Fever viruses

This study evaluates the antiviral potential of the clinical-stage drug ILB(R) against Dengue, Zika, and Yellow Fever viruses in human cells.

The Nef protein of the macrophage tropic HIV-1 strain AD8 counteracts human Bst-2/tetherin

This study shows that the HIV-1 AD8 strain uses its Nef protein to counteract tetherin restriction in the absence of Vpu, restoring virus release.

Comparative analysis reveals adaptive evolution of bat IFITMs and a novel antiviral determinant

The paper identifies adaptive evolution in bat IFITMs and a novel antiviral determinant involving S-palmitoylation at codon 70 and cysteine residues.